-------------------------------------------------------------------------------- | The Nordic Exchange | 19 January 2009 | -------------------------------------------------------------------------------- | Report on transactions of executives and related parties | | | in Coloplast shares and related securities | | -------------------------------------------------------------------------------- According to the Danish Securities Act § 28a Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities. -------------------------------------------------------------------------------- | Name | Lene Skole | -------------------------------------------------------------------------------- | Reason | Executive Management | -------------------------------------------------------------------------------- | Issuer | Coloplast A/S | -------------------------------------------------------------------------------- | ISIN code | DK0010309657 | -------------------------------------------------------------------------------- | Description | Shares | -------------------------------------------------------------------------------- | Transaction | Reception of shares as a flexible benefit (The | | | Danish Tax Assessment Act §7A) | -------------------------------------------------------------------------------- | Trade date | 29 December 2008 | -------------------------------------------------------------------------------- | Market | The Nordic Exchange | -------------------------------------------------------------------------------- | Number | 52 | -------------------------------------------------------------------------------- | Market value in DKK | 21,695.96 (Share price 15 January 2008: 417.23) | -------------------------------------------------------------------------------- Yours sincerely Coloplast A/S Agnete Ingvordsen This information is available in Danish and in English, in case of doubt the Danish version prevails. For further information: Agnete Ingvordsen, tel. +45 49 11 16 12.
Attachments
Recommended Reading
-
Friday, 6 February 2026 at 11:00-12:00am CETIn connection with the publication of Coloplast’s interim financial results for Q1 2025/26, to be released same day around 07.30am CET, Coloplast will host...
Read More -
Today, Coloplast is announcing changes to the company’s Executive Leadership Team (ELT). The changes relate to the company’s Interventional Urology business as well as the global People & Culture...
Read More